Per la Biorisonanza Magnetica e la Medicina Quantistica

  • Langevin HM. Connective tissue: a body-wide signaling network? Med Hypotheses. 2006;66(6):1074-7;
  • Cosic I, Pirogova E, Vojisavljevic V, Fang Q. Electro-magnetic properties of biomolecules. FME Transanct. 2006;34(2):71-8;
  • Hammerschlag R, et al. Biofield Physiology: A Framework for an Emerging Discipline. Glob Adv Health Med. 2015 Nov;4(Suppl):35-41;
  • Thaheld FH. An interdisciplinary approach to certain fundamental issues in the fields of physics and biology: towards a unified theory. Biosystems. 2005;80(1):41-56;
  • Kafatos MC, et al. Biofield Science: Current Physics Perspectives. Glob Adv Health Med. 2015 Nov;4(Suppl):25-34;
  • Ives J, van Wijk E, Bat N, et al. Ultraweak photon emission as a non-invasive health assessment: a systematic review. PLoS One. 2014;9(2):e87401
  • Rubik B. The biofield hypothesis: its biophysical basis and role in medicine. J Altern Complement Med. 2002. December;8(6):703–17;
  • Rein G. Bioinformation within the biofield: beyond bioelectromagnetics. J Altern Complement Med. 2004. February;10(1):59–68;
  • Cifra M, Fields J, Farhadi A. Electromagnetic cellular interactions. Prog Biophys Mol Biol. 2011;105(3):223–46;
  • Rossi C, et al. New perspectives in cell communication: Bioelectromagnetic interactions. Semin Cancer Biol. 2011;21(3):207–14;
  • Zhao Y, Zhan Q. Electric fields generated by synchronized oscillations of microtubules, centrosomes and chromosomes regulate the dynamics of mitosis and meiosis. Theor Biol Med Model. 2012. July 2;9:26;
  • Muehsam D, Ventura C. Life rhythm as a symphony of oscillatory patterns: electromagnetic energy and sound vibration modulates gene expression for biological signaling and healing. Global Adv Health Med. 2014;3(2):40–55;
  • McCraty R. The energetic heart: Bioelectromagnetic communication within and between people. In: Rosch P, Markov M, editors. , eds. Bioelectromagnetic Medicine. New York: Marcel Dekker; 2004:541–62;
  • Foletti A, et al. Bioelectromagnetic medicine: the role of resonance signaling. Electromagn Biol Med. 2013;32(4):484–99.
  • Glass L. Synchronization and rhythmic processes in physiology. Nature. 2001;410(6825):277-84;
  • Funk RH, Monsees TK, Ozkucur N. Electromagnetic effects—From cell biology to medicine. Prog Histochem Cytochem. 2009;43(4):177-264;
  • Funk RH, Monsees TK. Effects of electromagnetic fields on cells: physiological and therapeutical approaches and molecular mechanisms of interaction. A review. Cells Tissues Organs. 2006;182(2):59-78;
  • Kafatos MC, et al. Biofield Science: Current Physics Perspectives. Glob Adv Health Med. 2015 Nov;4(Suppl):25-34;
  • Muehsam D, et al. An Overview of Biofield Devices. Glob Adv Health Med. 2015 Nov;4(Suppl):42-51;
  • Heredia-Rojas JA, et al. Entamoeba histolytica and Trichomonas vaginalis: trophozoite growth inhibition by metronidazole electro-transferred water. Exp Parasitol. 2011;127(1):80-3;
  • Islamov BI, et al. Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med. 2002;134(3):248-50.
  • Belyaev IY, Alipov ED (2001). Frequency-dependent effects of ELF on chromatin conformation in Escherichia coli cells and human lymphocytes. Biophys Biochim Acta 1526:269–276;
  • Kafatos MC, et al. Biofield Science: Current Physics Perspectives. Glob Adv Health Med. 2015 Nov;4(Suppl):25-34.
  • Foletti A, et al. Cellular ELF signals as a possible tool in informative medicine. Electromagnetic Biol Med 2008, 28(1):71–79;
  • Lisi A, et al. (2008). Ion cyclotron resonance as a tool in regenerative medicine. Electromagn Biol Med 27:127–133;
  • Foletti A, et al. Bioelectromagnetic medicine: The role of resonance signaling. Electromagnetic Biology and Medicine, 2012; Early Online: 1–16;
  • Islamov BI, et al. Effect of bioresonance therapy on antioxidant system in lymphocytes in patients with rheumatoid arthritis. Bull Exp Biol Med. 2002 Sep;134(3):248-50;
  • Buiatti M, Longo G. Randomness and multilevel interactions in biology. Theory Biosci. 2013 Sep;132(3):139-58.
  • Vanwijk R. Bio-photons and bio-communication. J Sci Explor. 2001;15(2):183-97;
  • Fels D. Analogy between quantum and cell relations. Axiomathes.2012;22(4):509-20;
  • Scholkmann F, Fels D, Cifra M. Non-chemical and non-contact cell-to-cell communication:
  • a short review. Am J Transl Res. 2013;5(6):586-93;
  • Menas C. Kafatos, et al. Biofield Science: Current Physics Perspectives. Global Adv Health Med. 2015;4(suppl):25-34;
  • Daniel Fels. The Double-Aspect of Life. Biology 2018, 7, 0028; doi:10.3390/biology7020028;
  • Longo G, et al. Is information a proper observable for biological organization? Prog. Biophys. Mol. Biol. 2012, 109, 108–114;
  • Scholkmann F, Fels D; Cifra M. Non-chemical and non-contact cell-to-cell communication: A short review. Am. J. Transl. Res. 2013, 5, 586–593.

Per l’Ipertermia Oncologica

  • C. Marino, G.A. Lovisolo, “Campi elettromagnetici in terapia – Ipertermia”
  • http://www.elettra2000.it/scienza/lavoriScientifici/IpertermiaL2.htm, giugno 2005
  • F.A. Steward, J. Denekamp, “Fractionation studies with combined X-rays and hyperthermia in vivo”, Br J Radilo, vol. 52, pp. 346-356, 1980
  • N.B. Hornback, “Historical Aspects of Hyperthermia in Cancer Therapy”, Radiologic Clinics of North America, vol. 27, pp 481-487, 1989
  • W.C. Dewey, L.E. Hopwood, S.A. Sapareto, L.E. Gerweck, “Cellular responses to combinations and radiation”, Radiology, vol. 123, pp. 463-474, 1977
  • A.W. Guy, “History of biological and medical applications of microwave energy”, IEEE Trans Microwave Theory Tech, MTT 32, pp. 1182-1200, 1984
  • P. Vaupel, F. Kallinowski, “Physiological Effects of Hyperthermia”, Recent results in cancer Research, vol. 104, pp. 72-109, 1987
  • C. Marino, A.E. Cividalli, “Combined radiation and hyperthermia: Effect of the number of heat fractions and their sequence on normal and tumor tissues”, International Journal of Hyperthermia, vol. 8, pp. 771-781, 1992
  • C. Streffer, D. van Beuningen, “The biological basis for tumor therapy by hyperthermia and radiation”. Recent Results in Cancer Research, vol. 104, pp. 24-71, 1987
  • J. Overgaard, “The current and potential role of hyperthermia in radiotherapy”, Int. J. Radiation, Oncology, Biology and Physics, vol. 16, pp. 535-549, 1989
  • J.W. Hand, K. Hynynen, P.N. Shrivastava, T.K. Saylor, “Methods of external Hyperthermic heating”, Germany, M. Gautherie Edition, 1990
  • H. Kato, M. Hiraoka, T. Nakajima, T. Ishida, “Deep-heating characteristics of an RF capacitive heating device”, International Journal Hyperthermia, vol. 1, pp. 15-28, 1985
  • W. Hu, Q.He,C. Jiang. “Magetic iron oxid naoparticles: synthesis and surface functionalization strategies ”, Nanoscale Research Letters, Volume 3, Number 11 / November, 2008
  • R.K.Visaria, R.J.Griffin, B.W.Williams, G.F.Paciotti, C.W.Song. “enhancement of tumor termal therapy using gold nanoparticle-assisted tumor necrosis factor-α delivery”, Mol Cancer Therapy 2006 5
  • X.Huang, .K.Jain, I.H.El-Sayed, M.A.El-Sayed. “plasmonic phototermal teraphy using gold nanoparticle”, Lasers in Medical Science, Volume 23, Number 3 / July, 2008
  • P.P.Fortin, C.Wihelm, J.Servais,C.Menager “Size sorted anionic iron oxide nanomagnetes as colloidal mediators for magnetic hyperthermia ” JACS articles 2008
  • L.H.Pham, A.T.Nguyen, M.H.Do,H.V.Le “magnetic fluid based on Fe3O4 nanoparticle : preparation and hyperthemia application ” Jurnal of Physic conference series 187 (2009)
  • R.Hegat, R.Hiergeist, I.Hilger, Y.Lapatnikov “Maghemite nanoparticle with a very high class AC-loss for application in RF-magnetic hyperthermia”, Journal of magnetism and magnetic materials 270, 2004
  • M.Bettge, J.Chatterjee, Y.Haik “physically syntetized Ni-Cu nanoparticle for magnetic hyperthermia”,Biomagnetic Research and technology 2004
  • R.Hergt, S.Dutz, R.Muller, M.Zeisberger “ Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy ”, Jurnal of Physic /September 2008
  • Ville Alopaeus , Harry V. Norde, “A calculation method for multicomponent mass transfer coefficient Correlations” Computers and Chemical Engineering 23 (1999)
  • H.H. Pennes, “Analysis of tissue and arterial blood temperatures in the resting human forearm”, Journal. Applied. Physiolog., vol. 1, pp. 93-122, 1948
  • M. Pavel, G. Gradinariu, and A. Stancu “Study of the Optimum Dose of Ferromagnetic Nanoparticles Suitable for Cancer Therapy Using MFH”, IEEE Transactions on magnetic vol. 44, NO. 11, November 2008
  • M. Salloum, R.Ma, L.Zhu “Enachement in treatment planning for magnetic nanoparticle hyperthermia: optimization of th heat absorption pattern”, International Journal of Hyperthermia, June 2009 (25)
  • R.E. Rosensweig “Heating magnetic fluid with alternating magnetic field” , Journal of magnetism and magnetic materials 252, 2002
  • M. Salloum, R.Ma, L.Zhu,D.Weeks “controlling nanoparticle delivering in magnetic nanoparticle hyperthermia for cancer treatment: Experimental stydy in agarose gel” International Journal of Hyperthermia, June 2008 (24)
  • S.N.Tabatabaei S.Martel, “Hyperthermia via electromagnetic fiel and magnetic nanoparticles integrated in micro-carriers navigable in blood vassel”
  • P.J.Basser, Inferring Microstructural features and physiological state of tissues from diffusion weighted images,NMR in biomedicine Vol 8 333-344(1995)
  • M.Johannsen, U.Gneveckow, L.Eckelet,A. Feussner, R.scholz,P.Wust,S. Deger “Clinical hypertermia of prostate cancer using magnetic nanoparticle: Presentation of a new inerstial technique” International Journal of Hyperthermia, November 2005
  • P.Wust, U. Gneveckow, M.Johannsen, T.Henkel, F.Kahmann,J.Sehouli,R. Felix, J.Ricke, A.Jordan “Magnetic nanoparticles for interstizial thermotherapy – feasibility, tolerance and achieved temperatures” International Journal of Hyperthermia, December 2006
  • M. Salloum, R.Ma, L.Zhu, D. Weeks “Controlling nanoparticle delivery in magnetic nanoparticle hyperthermia for cancer treatment: Experimental study in agarose gel” International Journal of Hyperthermia, June 2008
  • B.Thiesen, A.Jordan “Clinical application fo magnetic nanoprticles for hyperthermia” International Journal of Hyperthermia, September 2006
  • A. Candeo, F. Dughiero “Numerical FEM Models for the Planning of Magnetic Induction Hyperthermia Treatments With Nanoparticles” esho 2009 VR
  • S.E.Barry “Challenges in the development of magnetic particles for terapeutica application ” Journal of Hyperthermia, September 2008
  • V.A.Atsarkin,L.V.Levkin, S.Posvyanskiy, O.V.Melnikov,M.N.Markelova, O.Y.Grbenko, A.R.Kaul “Solution to the bioheat equation for hyperthermia with La1-xAgyMnO3-δ nanoparticles: The effect of temperature autostabilization ” Journal of Hyperthermia, September 2009
  • H.G.Bagaria, D.T.Johnson “transient solution to the bioheat equation and optimization for magnetic fluid hyperthermia treatment” Journal of Hyperthermia, February 2005
  • Sheng Peng, Chao Wang, Jin Xie, Shouheng Sun “Synthesis and Stabilization of Monodisperse Fe Nanoparticles” J.A.C.S publication 2008
  • A. Candeo and F. Dughiero “Numerical FEM Models for the Planning of Magnetic Induction Hyperthermia Treatments With Nanoparticles”, IEEE Trans. On Mag., vol. 45
  • F. Dughiero, A. Candeo, E, Sieni, “Modelli numerici per il trattamento di tumori mediante ipertermia con nanoparticelle”
  • S.Bicciato “Biongegneria cellulare 2008” Appunti lezione
  • Shigeru Fujimoto, Makoto Takahashi, Takaaki Mutou, Kokuriki Kobayashi, Tadashi Toyosawa, Eiji Isawa, Megumi Sumida, Haruo Ohkubo: Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis traeted with imtraperitoneal hypertemic chemoperfusion combined with surgey. Cancer 1997; 79: 884-91
  • Fujimoto S., Shrestha R.D., Kokubun M., Ohta M., Takahashi K., et al.: Intraperitoneal hypertemic perfusion combined with surgey effective for gastric cancer patiens with peritoneal seeding. Ann. Surg. 1998; 208: 36-41
  • Sugarbaker Ph., Graves T., De Bruijn E.A., Cunliffe W.J., Mullins R.E., Hull W.E., et al.: Early postoperative intraperitoneal chemoterapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res. 1990; 50: 5790-4
  • Fujimoto S., Shresta R.D. Kokubun M., Kobayashi K., Kiuchi S., Konno C., et al.: Pharmacokinetic analysis of mytomicin C for intraperitonel hyperthermic perfusion in patients with far-advanced or recurrent gastric cancer. Reg. Cancer Treat, 1989; 2: 198-202
  • Gilly F.N., Sayang A.C., Carry P.Y., Braillon G., James J., Vollocha A., et at.: Intraperitoneal Chemohyperthermia: a new terapy in the treatment for peritoneal seeding. Int. Surg. 1991; 76: 164-7
  • Kober F., Heiss A., Roka R.: Grundlagen und Tecnik der intrapritonealen hypertermen Chemoperfusion (IHCP): Erste Erfahrungen bei diffuser Carcinosis peritonei. Actha Chir. Austriaca 1995; 27: 87-9
  • Leveen H.H., Wapncih G., Piccone V.A., Falck G., Ahmed R.: Tumor eradication by radiofrequency Thermotherapy. JAMA 1976, 235: 2198-2200
  • Pontiggia P., McLaren J., Baronzio G., Freitas I.: The biological response to Heat. In Consensus on Hypertermia for the 1990s. Ad. Exp. Med. Biol. 1009; 267: 1-516
  • Pontiggia P., Introzzi A.: The therapeutic anhancement caused by hytertermia. Med. Biol. Environ. 1988; 16: 499
  • Dahl O.: Mechanisms of thermal enhancement of chemotherapeutic cytotoxicity in hypertermia and oncology. Urano and Douple, eds. VSP Utrecht 1994
  • Pontiggia P., Mathè G.: A new mode of cancer cell death induced by hyperthermia and non specific (macrofagic) cancer immunotherapy: lysosomal exocytosis. Biomed. Pharmacother. 1994; 48: 331
  • Pontiggia P., Barni S., Mathè G., Bertone V., Pontiggia E.: Lysosomal exocytosis induced by hypertermia: a new mode of cancer death. II. Effect on peritoneal macrophages. Biomed. Pharmacother. 1995, 49
  • Rau Beate, Wust Peter, Hohenberger Peter, Loffel, Hunerbein Michael, Below Cathlen, Gellerman Johanna, Speidel Andrea, Vogl Thomas, Riess Hanno, Felix Roland, Schlag Peter M.: Preoperative hypertermia combined with radiochemoterapy in locally advanced rectal cancer. Annals of Surgery 227, 3. 380-389; 1998
  • Rietbroek Ron, Schilthuis Marten S., Bakker Piet J.M., Van Dijk Jan D.P., Postma Arjan J., Gonzàles Gonzàles Dioniso, Bakker Ad J., Van der Velden Jacobus, Helmerhost Theo J.M., Veenhof Cees H.N.: Phase II trail of weekly locoregional hypertermia and cisplatin in patients with a previuosly irradiated recurrent carcinoma of the uterin cervix. Cancer 1997; 79: 935-43
  • Dahl O., Mella O.: Hypertermia and chemotherapeutic agents. In: Field S.B., Hand J.W. editors: An introduction to the practical agents of clinical hypertemia. London PA: Taylor and Francis, 1990: 108-33
  • Urano M., Kahn J., Majima H., Gerwech L.E.: The cytotoxix effect of cisdiamminedichloroplatinum (II) on cultured Chinese hamster ovary cells at elevated temperatures: Arrhenius plot analysis. Int. J. Hyperthermia 1990; 6: 581-90
  • Los G., Van Vugt M.J.H., Pinedo H.M.: Response of peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br. J. Cancer 1994; 69: 235-41
  • Issels R.D., Wadepohl M., Tilling K., Muller M., Sauer H., Willmanns W.: Regional hypertermia combined with systemic chemotherapy in advanced abdominal and pelvis tumors; first result of a pilot study employng an annular phased array applicator. Recent Result Cancer Res. 1988; 107: 236-43
  • Hahn G.M.: Hyperthermia and cancer. New York: Plenum Press., 1982
  • Zajicek G.: Adjuvant chemotherapy od breast cancer should be banned. The Cancer J., 1996; 9, 4
  • Leeven H.H., Wapnicks G., Piccone V.A., Falck G. and Ahmed N.: Tumor eradication by Radiofrequency Thermotherapy. Jama, 1976; 235, 2198
  • Leeven H.H., Ragagopalan P.R., Vujic I., Gobian R., Pontiggia P., D’Ovidio N., Pething R. and Armitage D.: Radiofrequency Thermotherapy, Local Chemotherapy and Arterial Occlusion in the Treatment of non Resectable Cance. Am. Surgeon, 1984: 50, 61
  • Mokyr M.B., Drays S.: Interplay between the toxic effects of anticamcer drugs and host antitumor imminity in carcer therapy. Clinical invest. 1978; 5, 31
  • Alonso K., Pontiggia P., Sabato, et al.: Systemic hypertermia in the treatment of HIV related disseminated Kaposi’s Sarcoma. Long-term follow-up of patients treated with low flow extracorporeal perfusional hypertermia. Am. J. Clin. Oncol., 1994; 17, 353
  • Pontiggia P., Santamaria A., Bianchi, Alonso K., Santamaria K.: Whole body hypertermia associated with betacarotene supplementation in patients with AIDS. Biomed and Pharmacoth., 1995; 5, 263
  • Engalahrdt R.: Whole-body hypertermia in “Abstract of the 5th Intern, Symp. on Hypertermic Oncology”. Kyoto, Japan, 1988
  • Di Filippo F., Carini S., Cavaliere F., Giannelli D., Cavallero L., et al.: The role of Hypertermic Perfusion I in hte Treatment of Tumors of the Extremities, In “Consensus on Hyperermia for the 1990’s”. Adv. Exp. Med. and Biol. Vol. 267, Plenum Press., 1990
  • Hugander A.: Hyperthermia and the liver, in “Consensue of hyperthermia for the 1990’s”, Adv. Exp. Med. and Biol. Vol. 267, Plenum Press. 1990
  • Fujimoto S., Takatasti M., Okui K.: A prospective study on combined treatment of intraperitoneal hyperthermic chemotherapy and surgey for patients with refractory gastric cancer. In mytomicin C in cancer chemotherapy today. Proceedings 15th Int. Congress, Hamburg, Excepta Medica, 1990
  • Bicher H.I., Moore D.W., Wolfstein R.S.: A method for interstitial thermoradiotherapy. In Overgaard J. (Ed.); Hyperthermic Oncology. 1984, Taylor and Francis, London and Philadelphia, 1984; pp. 595-598

American Cancer Society. (2016, May 3). Hyperthermia to Treat Cancer. Retrieved from: https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/hyperthermia.html.

Fong Y, Dupuy DE, Feng M, Abou-Alfa G. Cancer of the liver. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 52:696-714.

Gosselin TK. Principles of radiation therapy. Yarbro CH, Wujcki D, Holmes Gobel B, (eds.). (2016). Cancer Nursing: Principles and Practice. (8th Edition). Burlington, MA: Jones and Bartlett Learning. 11: 267-284.

National Cancer Institute. (2011, August 31). Hyperthermia in Cancer Treatment. Bethesda: National Cancer Institute (NCI).

Tombesi P, Di Vece F, Sartori S. Resection vs thermal ablation of small hepatocellular carcinoma: What’s the first choice?. (2013, January 28). World Journal of Radiology. Baishideng Publishing Group. 5(1):1-4 (PMID: 23493926).

US National Library of Medicine. (2015, September 13). Hyperthermia for Treating Cancer. Retrieved from: https://medlineplus.gov/ency/patientinstructions/000904.htm.

Viglianti BL, Stauffer P, Repasky E, et al. Hyperthermia. Hong WK, et al (eds.). (2010). Holland Frei Cancer Medicine. (8th Edition). People’s Medical Publishing House. 42: pp.528-540.

Nota importante: Una possibile fonte di ricerche sui numerosi studi compiuti in questi anni si offre nella banca dati degli studi della PubMed.